What's on

  • February 2, 2016

    IDIBAPS takes part in a 30 million euros project to develop new HIV vaccines

    IDIBAPS takes part in the European HIV Vaccine Alliance (EHVA) to develop and evaluate new preventive and therapeutic vaccines. The European Commission grants with over 22 million euros in addition to the 6 million euros from Swiss Government. This effort is part of the European Commission Framework Programme for Research and Innovation (Horizon2020) and gathers together HIV leading scientists from 39 public institutions along with European, North American and African companies. Dr. Josep M. Gatell, head of the Infectious Diseases and AIDS IDIBAPS team, is the coordinator from this centre, and Drs. Felipe García, Montserrat Plana and Eloisa Yuste, researchers from the same group, also would join the project. The Spanish National Centre for Biotechnology of the CSIC (CNB-CSIC) also participates.

    Read the rest of this entry

  • January 26, 2016

    A study identifies areas of the genome involved in the response to lithium in bipolar disorder

    Researchers from Hospital Clínic, IDIBAPS, University of Barcelona (UB) and Mental Health Research Center (CIBERSAM), associated with  Institute of Health Carlos III (ISCIII), have taken part in an international study, published in the prestigious journal The Lancet, where a region of the genome involved in the response to lithium in bipolar disorder has been discovered. This study is the largest genetic analysis using GWAS (Genome-Wide Association Study) carried out regarding the response to this medication so far and included data from more than 2,500 patients with the disease.

    Read the rest of this entry

  • January 25, 2016

    IDIBAPS and Fundació Clínic take part in EATRIS and ECRIN, two European Research Infrastructure Consortium

    IDIBAPS and Fundació Clínic take part in two of the ERIC (European Research Infrastructure Consortium) consortiums promoted by the European Commission for the establishment and functioning of research infrastructure networks in the EU. These consortiums provide groups and research institutions services related to their activity and allow them to directly participate as members of European projects.

    Read the rest of this entry

  • January 22, 2016

    A nutritional combination of saturated fatty acids can induce steatohepatitis

    Researchers from the IIBB-CSIC and IDIBAPS have published an article in Oncotarget journal in which they have shown for the first time that diets enriched in two types of saturated fatty acids - palmitic and myristic - induce the development of steatohepatitis, an advanced stage of the fatty liver disease, and promotes fat to accumulate in the liver which causes inflammation. The coordinators of this study are Dr. Jose C. Fernández-Checa, Head of the Mitochondrial Regulation of Cell Death and Steatohepatitis IDIBAPS team, and Dr. Carmen García-Ruiz, researcher at the same team. Dr. Laura Martinez, post-doctoral researcher at Dr. Fernández-Checa’s group, is the first author of the study.

    Read the rest of this entry

  • January 15, 2016

    Four researchers at Hospital Clínic and IDIBAPS among the 2015 most cited scientists

    Dr. Jordi Bruix, Head of the hepatic Oncology Unit at Hospital Clínic de Barcelona, the Hepatic Oncology IDIBAPS research team, the Barcelona Clinic Liver Cancer (BCLC) and scientific director of CIBEREHD; Dr. Josep Dalmau, ICREA Professor and Head of the Pathogenesis of autoimmune neuronal disorders IDIBAPS research group; Dr. Josep Maria Llovet, ICREA Professor, Head of the Translational research in hepatic oncology research group at IDIBAPS and Director of Mount Sinai Liver Cancer Program at the Icahn School of Medicine at Mount Sinai (New York); and Dr. Eduard Vieta, head of the Psychiatry and Psychology Department at Hospital Clínic and leader of Bipolar Disorders team at IDIBAPS, are among the most influential names in science and appear in the Highly Cited Researchers 2015 list published by Thomson Reuters.

    Read the rest of this entry

PreviousNext

Events

  • Tuesday, 02/16/2016 · Diabetes and Obesity Research Laboratory Seminar

    Antonio del Sol, PhD

    Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg

    Systems Biology Approaches to Stem Cell Research and Disease Modeling
    Day:
    02/16/2016
    Place:
     Esteve Auditorium. CEK Building. Rosselló 149. 08036 Barcelona
    Schedule:
    3 PM
  • Tuesday, 02/23/2016 · IDIBAPS IN-HOUSE Seminar

    José Luís Molinuevo, MD PhD

    IDIBAPS Team Leader Alzheimer´s disease and other cognitive disorders

    Redefining Alzheimer disease
    Day:
    02/23/2016
    Place:
     Esteve Auditorium. CEK Building. Rosselló 149. 08036 Barcelona
    Schedule:
    3 PM
  • Friday, 02/26/2016 · Campus Clinic Cancer Seminar

    Silvia Beà, PhD

    IDIBAPS Researcher Human and experimental functional oncomorphology

    The complex landscape of genetic alterations in lymphoid neoplasms
    Day:
    02/26/2016
    Place:
    Room 2. School of Medicine. Casanova 143, 08036 Barcelona
    Schedule:
    1 PM
  • Monday, 02/29/2016 · IDIBAPS Seminar

    Lorenzo Albertazzi, PhD

    Institute for Bioenginering of Catalonia (IBEC). Barcelona

    Super resolution microscopy of targeted cancer therapies
    Day:
    02/29/2016
    Place:
     Esteve Auditorium. CEK Building. Rosselló 149. 08036 Barcelona
    Schedule:
    3 PM
  • Monday, 03/07/2016

    ILCA School of Liver Cancer 2016

    Liver Cancer: Future Prospects in Management and Research

    Day:
    03/07/2016
    Place:
    The venue of the ILCA School of Liver Cancer 2016 is School of Medicine, University of Barcelona (Paranimf Hall).
    Schedule:
    9 AM

More events